1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one

C133H126N18O10 — CID 161215405

IUPAC1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one
SMILESCOCCn1cc(-c2ccc(CC(=O)Cc3c(-c4ccccc4)ccc4cncn34)cc2)cn1.O=C(Cc1ccc(-c2cn[nH]c2)cc1)Cc1c(-c2ccccc2)ccc2cncn12.O=C(Cc1ccc(C(=O)CCCCN2CCOCC2)cc1)Cc1c(-c2ccccc2)ccc2cncn12.O=C(Cc1ccc(C(=O)CCCN2CCOCC2)cc1)Cc1c(-c2ccccc2)ccc2cncn12.O=C(Cc1ccn[nH]1)Cc1c(-c2ccccc2)ccc2cncn12
InChIInChI=1S/C31H33N3O3.C30H31N3O3.C28H26N4O2.C25H20N4O.C19H16N4O/c35-28(21-30-29(25-6-2-1-3-7-25)14-13-27-22-32-23-34(27)30)20-24-9-11-26(12-10-24)31(36)8-4-5-15-33-16-18-37-19-17-33;34-27(20-29-28(24-5-2-1-3-6-24)13-12-26-21-31-22-33(26)29)19-23-8-10-25(11-9-23)30(35)7-4-14-32-15-17-36-18-16-32;1-34-14-13-31-19-24(17-30-31)22-9-7-21(8-10-22)15-26(33)16-28-27(23-5-3-2-4-6-23)12-11-25-18-29-20-32(25)28;30-23(12-18-6-8-19(9-7-18)21-14-27-28-15-21)13-25-24(20-4-2-1-3-5-20)11-10-22-16-26-17-29(22)25;24-17(10-15-8-9-21-22-15)11-19-18(14-4-2-1-3-5-14)7-6-16-12-20-13-23(16)19/h1-3,6-7,9-14,22-23H,4-5,8,15-21H2;1-3,5-6,8-13,21-22H,4,7,14-20H2;2-12,17-20H,13-16H2,1H3;1-11,14-17H,12-13H2,(H,27,28);1-9,12-13H,10-11H2,(H,21,22)
InChIKeyUWUHEYXZDAZRCK-UHFFFAOYSA-N
MW2136.59 g/mol
LogP22.38
Rot. Bonds41

About 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one

1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one (PubChem CID 161215405) has the molecular formula C133H126N18O10 and a molecular weight of 2136.59 g/mol. Its IUPAC name is 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one.

Molecular Properties

Compound Name1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one
PubChem CID161215405
Molecular FormulaC133H126N18O10
Molecular Weight2136.59 g/mol
Exact Mass2134.99
IUPAC Name1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one
SMILESCOCCn1cc(-c2ccc(CC(=O)Cc3c(-c4ccccc4)ccc4cncn34)cc2)cn1.O=C(Cc1ccc(-c2cn[nH]c2)cc1)Cc1c(-c2ccccc2)ccc2cncn12.O=C(Cc1ccc(C(=O)CCCCN2CCOCC2)cc1)Cc1c(-c2ccccc2)ccc2cncn12.O=C(Cc1ccc(C(=O)CCCN2CCOCC2)cc1)Cc1c(-c2ccccc2)ccc2cncn12.O=C(Cc1ccn[nH]1)Cc1c(-c2ccccc2)ccc2cncn12
InChIInChI=1S/C31H33N3O3.C30H31N3O3.C28H26N4O2.C25H20N4O.C19H16N4O/c35-28(21-30-29(25-6-2-1-3-7-25)14-13-27-22-32-23-34(27)30)20-24-9-11-26(12-10-24)31(36)8-4-5-15-33-16-18-37-19-17-33;34-27(20-29-28(24-5-2-1-3-6-24)13-12-26-21-31-22-33(26)29)19-23-8-10-25(11-9-23)30(35)7-4-14-32-15-17-36-18-16-32;1-34-14-13-31-19-24(17-30-31)22-9-7-21(8-10-22)15-26(33)16-28-27(23-5-3-2-4-6-23)12-11-25-18-29-20-32(25)28;30-23(12-18-6-8-19(9-7-18)21-14-27-28-15-21)13-25-24(20-4-2-1-3-5-20)11-10-22-16-26-17-29(22)25;24-17(10-15-8-9-21-22-15)11-19-18(14-4-2-1-3-5-14)7-6-16-12-20-13-23(16)19/h1-3,6-7,9-14,22-23H,4-5,8,15-21H2;1-3,5-6,8-13,21-22H,4,7,14-20H2;2-12,17-20H,13-16H2,1H3;1-11,14-17H,12-13H2,(H,27,28);1-9,12-13H,10-11H2,(H,21,22)
InChIKeyUWUHEYXZDAZRCK-UHFFFAOYSA-N
XLogP22.38
TPSA315.34 Ų
H-Bond Donors2
H-Bond Acceptors26
Rotatable Bonds41
Heavy Atoms161
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002136.59
LogP ≤ 522.38
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one?
The IUPAC name of 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one (CID 161215405) is 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one.
What is the SMILES notation for 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one?
The canonical SMILES for 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one is COCCn1cc(-c2ccc(CC(=O)Cc3c(-c4ccccc4)ccc4cncn34)cc2)cn1.O=C(Cc1ccc(-c2cn[nH]c2)cc1)Cc1c(-c2ccccc2)ccc2cncn12.O=C(Cc1ccc(C(=O)CCCCN2CCOCC2)cc1)Cc1c(-c2ccccc2)ccc2cncn12.O=C(Cc1ccc(C(=O)CCCN2CCOCC2)cc1)Cc1c(-c2ccccc2)ccc2cncn12.O=C(Cc1ccn[nH]1)Cc1c(-c2ccccc2)ccc2cncn12.
What is the InChIKey of 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one?
The InChIKey is UWUHEYXZDAZRCK-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H33N3O3.C30H31N3O3.C28H26N4O2.C25H20N4O.C19H16N4O/c35-28(21-30-29(25-6-2-1-3-7-25)14-13-27-22-32-23-34(27)30)20-24-9-11-26(12-10-24)31(36)8-4-5-15-33-16-18-37-19-17-33;34-27(20-29-28(24-5-2-1-3-6-24)13-12-26-21-31-22-33(26)29)19-23-8-10-25(11-9-23)30(35)7-4-14-32-15-17-36-18-16-32;1-34-14-13-31-19-24(17-30-31)22-9-7-21(8-10-22)15-26(33)16-28-27(23-5-3-2-4-6-23)12-11-25-18-29-20-32(25)28;30-23(12-18-6-8-19(9-7-18)21-14-27-28-15-21)13-25-24(20-4-2-1-3-5-20)11-10-22-16-26-17-29(22)25;24-17(10-15-8-9-21-22-15)11-19-18(14-4-2-1-3-5-14)7-6-16-12-20-13-23(16)19/h1-3,6-7,9-14,22-23H,4-5,8,15-21H2;1-3,5-6,8-13,21-22H,4,7,14-20H2;2-12,17-20H,13-16H2,1H3;1-11,14-17H,12-13H2,(H,27,28);1-9,12-13H,10-11H2,(H,21,22).
What are the key properties of 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one?
1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one has a molecular weight of 2136.59 g/mol, XLogP of 22.38, 41 rotatable bonds, 2 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propan-2-one;4-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]butan-1-one;5-morpholin-4-yl-1-[4-[2-oxo-3-(6-phenylimidazo[1,5-a]pyridin-5-yl)propyl]phenyl]pentan-1-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-[4-(1H-pyrazol-4-yl)phenyl]propan-2-one;1-(6-phenylimidazo[1,5-a]pyridin-5-yl)-3-(1H-pyrazol-5-yl)propan-2-one is sourced from PubChem (CID 161215405), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).